Why Physician-Guided, Methylation-Aware Care Matters for FRAT-Positive Patients Folate receptor-alpha autoantibodies (FRAA) can block folate transport into the brain and, for many patients, justify a trial of folinic acid (leucovorin)
Injectable administration bypasses digestive breakdown entirely, allowing lower doses to produce stronger results
Low-quality or mislabeled products waste money and may cause harm
None of the mechanisms below should be read as therapeutic effects in humans
In the development of the GLP-1 receptor agonist, semaglutide, the strategy used to extend the drugs half-life was to promote covalent and non-covalent binding of semaglutide to albumin through the addition of a fatty-acid attachment on semaglutide
our work in Healing & Total Recovery Research constantly reminds us of the body's intricate repair mechanisms